Accoring to research report the Cardiac Monitoring Devices Market is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025.
Browse
336 market data Tables and 40 Figures spread through 266 Pages and
in-depth TOC on "Cardiac Monitoring & Cardiac Rhythm Management
Devices Market by Product, CM (ECG (Holter Monitor), ILR, Event
Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P,
Dual Chamber Pacemaker)), End User & Region – Global Forecast to
2025"
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55
The
growth of this market is driven by the increasing prevalence of
cardiovascular diseases; availability of reimbursement for CM & CRM
devices; launch of innovative products by market players; increasing
investments, funds, and grants for research on CM & CRM devices; and
the growing preference for wearable cardiac devices.
ECG Devices is expected to hold the largest share of the cardiac monitoring devices market in 2020
On
the basis of cardiac monitoring devices by type, the market is
segmented into ECG devices, event monitors, implantable loop recorders
(ILRs), cardiac output monitoring (COM) devices, mobile cardiac
telemetry (MCT) devices, and smart ECG monitors. In 2019, the ECG
devices segment accounted for the largest share of the cardiac
monitoring devices market. The large share of this segment can be
attributed to technological advancements such as the incorporation of
advanced algorithms and workflow improvement features, such as
simplified operations, touchscreen systems, portability, wireless
features, and better connectivity with cardiovascular information
systems (CVIS), electronic medical records (EMRs), and ECG management
systems.
Defibrillators is expected to hold the largest share of the cardiac rhythm management devices market in 2020
On
the basis of cardiac rhythm management devices by type, the market is
segmented into defibrillators and pacemakers. In 2019, the
defibrillators segment accounted for the largest market share. This
segment is also projected to register the highest CAGR during the
forecast period. Factors such as technological advancements in
defibrillators, rising prevalence of CVD, and growing focus on providing
public-access defibrillators are driving the growth of this market.
Hospitals segment commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2020
By
end user, the cardiac monitoring & cardiac rhythm management
devices market is segmented into hospitals; clinics, cardiac centers,
and ambulatory surgery centers (ASCs); and other end users. Hospitals
accounted for the largest share of the cardiac monitoring & cardiac
rhythm management devices market in 2019. The large share of this
segment can be attributed to factors such as the increasing prevalence
of CVD, the growing number of patient visits to hospitals for diagnosis,
increasing number of cardiac implant procedures, and the availability
of reimbursement for these procedures across developed markets.
North America commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2020.
On
the basis of region, the cardiac monitoring & cardiac rhythm
management devices market is segmented into North America, Europe, Asia
Pacific, and Rest of the World. In 2019, North America commanded the
largest share of the cardiac monitoring & cardiac rhythm management
devices market. The large share of this market segment can be attributed
to the increasing incidence of CVD, increasing healthcare expenditure,
growing disposable income, growing healthcare awareness, and the
availability of technologically advanced devices in the region.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=55
The
major players operating in this market are Medtronic (Ireland), Boston
Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK
(Germany), and Koninklijke Philips (Netherlands), Asahi Kasei
Corporation (Japan), MicroPort Scientific Corporation (China), Hill-Rom
Holdings (US), Nihon Kohden (Japan), SCHILLER AG (Switzerland),
BioTelemetry (US), BPL Medical Technologies (India), ACS Diagnostics
(US), Shenzhen Mindray Bio-Medical Electronics (China), Lepu Medical
Technology (China), Shree Pacetronix (India), OSYPKA (Germany), and BTL
t(US), Alivecor, Inc. (US), Amiitalia (Italy), Bexen Cardio (Spain),
Narang Medical Limited (India), MeTrax GmbH (Germany), and Progetti Srl
(Italy).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com